Status:
COMPLETED
The Effect of Optic Flow Speed Manipulation and the Level of Immersion on the Gait Pattern in People Post-stroke
Lead Sponsor:
Vrije Universiteit Brussel
Collaborating Sponsors:
University Ghent
University Hospital, Ghent
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to investigate the effect of manipulating the optic flow speed in the virtual environment on the gait pattern during virtual reality (VR) - enhanced treadmill walking in peopl...
Detailed Description
STUDY DESIGN This study is an experimental, 2-group, multicenter trial in which people post-stroke and healthy people will perform 2 different sessions of treadmill walking. The 2 sessions will be ca...
Eligibility Criteria
Inclusion
- Inclusion Criteria stroke patients:
- diagnosed with stroke (as defined by the World Health Organization)
- stroke onset ≥ 3 months
- ambulatory with an impaired gait pattern (FAC-score 2, 3 or 4)
- ability to walk on a treadmill for 4x8 minutes without bodyweight support
- adult (≥ 18 years)
- ability to signal pain, fear and discomfort
- ability to give informed consent
- Exclusion Criteria stroke patients:
- other neurological deficits than stroke leading to impaired gait (e.g. Parkinson's disease, multiple sclerosis)
- comorbidities (e.g. COPD, severe osteoporosis, cardiovascular instability)
- visual and/or vestibular disorders that can interfere with the VR
- uncontrolled spasticity significantly interfering with the movement of the lower extremities (Modified Ashworth Scale \> 2)
- acute medical illness
- communicative/cognitive problems leading to the inability to understand and carry out instructions
- severe unilateral spatial neglect
- Inclusion Criteria healthy people:
- ≥ 18 years of age
- normal or corrected-to-normal vision with glasses or contact lenses,
- no locomotion impairments
- Exclusion Criteria healthy people:
- having a significant lower extremity injury during the last two years that might affect their gait
- having any type of vestibular/visual deficiency
Exclusion
Key Trial Info
Start Date :
October 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 23 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04521829
Start Date
October 10 2020
End Date
June 23 2022
Last Update
June 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emma De Keersmaecker
Brussels, Belgium, 1090